Trials / Completed
CompletedNCT02914340
REACH SVS Control Patient Cross-Over Study
REACH (Research to Assess SVS Safety and Effectiveness for the Treatment of Severe EmphysemA in China) SVS Control Patient Cross-Over Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Olympus Corporation of the Americas · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, prospective study designed to evaluate performance of the SVS in the REACH SVS control patients. The study is expected to enroll up to 20 patients at up to 12 sites with up to 6 patients per site.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spiration Valve System |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-06-01
- Completion
- 2018-09-01
- First posted
- 2016-09-26
- Last updated
- 2018-10-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02914340. Inclusion in this directory is not an endorsement.